Price movement over the last 24 hours
Align Technology, Inc. vs Aterian Inc — how do they compare? Align Technology, Inc. trades at $176.3 (market cap $13.27B), while Aterian Inc trades at $1.23 (market cap $13.25M). The key difference: Align Technology, Inc. is far larger — about 1001.5× Aterian Inc's market cap. Which is the better fit depends on your goals.
| ALGN | ATER | |
|---|---|---|
Market Cap | $13.27B | $13.25M |
Sector | Health | Consumer Cyclical |
52-Week High | $207.19 | $1.55 |
52-Week Low | $124.88 | $0.54 |
Enterprise Value | $12.32B | $13.83M |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
Aterian (ATER) trades at $1.24, down 3.12% today, with a bullish technical signal from moving averages. The company shows improving operational trends with three consecutive quarterly earnings beats, though it remains unprofitable with a -30.78% net margin. Recent news highlights a special stockholders meeting on July 10, 2026, to vote on proposals that could return $0.85–$1.14 per share.
Investment outlook is mixed: positive technical momentum and potential shareholder returns contrast with persistent losses and negative cash flow. Key risks include sustained unprofitability and high short interest growth of 57.7% in March 2026. Analysts are evenly split between Buy and Hold ratings, reflecting cautious optimism amid fundamental challenges.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →